These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16123338)

  • 1. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver.
    Park SY; Cho YR; Finck BN; Kim HJ; Higashimori T; Hong EG; Lee MK; Danton C; Deshmukh S; Cline GW; Wu JJ; Bennett AM; Rothermel B; Kalinowski A; Russell KS; Kim YB; Kelly DP; Kim JK
    Diabetes; 2005 Sep; 54(9):2514-24. PubMed ID: 16123338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
    Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
    J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice.
    Chen W; Chen W; Xia Y; Zhao X; Wang H; Yu M; Li Y; Ye H; Zhang Y
    Mol Biol Rep; 2013 Mar; 40(3):2449-59. PubMed ID: 23196711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation.
    de Souza CO; Teixeira AAS; Biondo LA; Lima Junior EA; Batatinha HAP; Rosa Neto JC
    J Cell Physiol; 2017 Aug; 232(8):2168-2177. PubMed ID: 27925195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.
    Park SY; Kim HJ; Wang S; Higashimori T; Dong J; Kim YJ; Cline G; Li H; Prentki M; Shulman GI; Mitchell GA; Kim JK
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E30-9. PubMed ID: 15701680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T; Tsunoda M; Mochizuki T; Murakami K
    Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα.
    Guo Y; Yu J; Deng J; Liu B; Xiao Y; Li K; Xiao F; Yuan F; Liu Y; Chen S; Guo F
    Diabetes; 2016 Aug; 65(8):2151-63. PubMed ID: 27207553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
    Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
    Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
    Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
    Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.
    Burkart EM; Sambandam N; Han X; Gross RW; Courtois M; Gierasch CM; Shoghi K; Welch MJ; Kelly DP
    J Clin Invest; 2007 Dec; 117(12):3930-9. PubMed ID: 18037994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD36 deficiency rescues lipotoxic cardiomyopathy.
    Yang J; Sambandam N; Han X; Gross RW; Courtois M; Kovacs A; Febbraio M; Finck BN; Kelly DP
    Circ Res; 2007 Apr; 100(8):1208-17. PubMed ID: 17363697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo.
    Berglund ED; Kang L; Lee-Young RS; Hasenour CM; Lustig DG; Lynes SE; Donahue EP; Swift LL; Charron MJ; Wasserman DH
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E607-14. PubMed ID: 20663988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
    Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
    Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.